CRO for Clinical Trials in Japan
Japan is one of the most strategic countries in Asia to run clinical trials. Sponsors select Japan to conduct their clinical studies due to the high quality of research and the high volume of patients offered by Japanese sites. The clinical trial database of the US (clinicaltrials.gov), as of June 2021, indicated that 6,541 clinical studies included the participation of a Japanese hospital.
Japan has a total population of about 125 million people, which offers substantial potential to conduct clinical trials across different disease types. In addition, the country has prestigious hospitals located in the main cities: Tokyo, Yokohama, and Osaka.
Sofpromed provides high-quality CRO services for biotechnology and pharmaceutical firms planning to include Japanese hospitals in their clinical trials.
Our CRO services in Japan include:
- Regulatory submissions and reporting
- Ethics committee submissions and reporting
- Clinical operations
- Hospital selection and activation
- Clinical site management
- Clinical monitoring
- Data management
- Biostatistics and SAS statistical programming
- Medical writing
- Clinical study logistics (including biological samples, drugs, and supplies)
Among others, we are able to manage clinical trials in these therapeutic areas in Japan:
- Oncology
- Hematology
- Cardiovascular
- Metabolic
- Central nervous system (CNS)
- Dermatology
- Infectious diseases
- Respiratory diseases
- Pain